In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: Regulation by glutathione redox state

Journal of Neurochemistry

Volumn 101, Issue 3, 2007, Pages 709-717

  Calabrese, Vittorio ^a,e   Mancuso, Cesare ^b   Ravagna, Agrippino ^a   Perluigi, Marzia ^c   Cini, Chiara ^c   Marco, Carlo De ^c   Allan Butterfield, D ^d   Stella, Anna Maria Giuffrida ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

Glutathione; Heat shock protein; Levodopa; Mitochondria; Nitrosative stress; Substantia nigra

Indexed keywords

3 NITROTYROSINE; 3,4 DIHYDROXYPHENYLACETIC ACID; CARBIDOPA; CYTOCHROME C OXIDASE; DOPA DECARBOXYLASE INHIBITOR; DOPAMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; LEVODOPA; MITOCHONDRIAL PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; MALE; NEUROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SUBSTANTIA NIGRA;

ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX I; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLUTATHIONE; HEAT-SHOCK PROTEINS; LEVODOPA; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; TIME FACTORS;

RATTUS;

EID: 34247326430     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04367.x     Document Type: Article

References (56)

1. Abdul H. M., Calabrese V., Calvani M. Butterfield D. A. (2006) Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J. Neurosci. Res. 84, 398 408.
2. Ahlskog J. E. (2001) Parkinson's disease: medical and surgical treatment. Neurol. Clin. 19, 579 605.
3. Aminoff M. J. (2001) Pharmacologic management of parkinsonism and other movement disorders, in Basic and Clinical Pharmacology, 8th Edn (Foltin J., Ransom J., Nogueira I., Davis K. Katzung B.G., eds pp. 463 477. Lange Medical Books/McGraw-Hill, Columbus, OH, USA.
4. Beal M. F. (1998) Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann. Neurol. 44, S110 S114.
5. Boje K. M. (2004) Nitric oxide neurotoxicity in neurodegenerative diseases. Front. Biosci. 9, 763 776.
6. Calabrese V., Bates T. E. Giuffrida Stella A. M. (2000a) NO synthase and NO dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem. Res. 25, 1315 1341.
7. Calabrese V., Testa G., Ravagna A., Bates T. E. Stella A. M. (2000b) HSP70 induction in the brain following ethanol administration in the rat: regulation by glutathione redox state. Biochem. Biophys. Res. Commun. 269, 397 400.
8. Calabrese V., Scapagnini G., Giuffrida Stella A. M., Bates T. E. Clark J. B. (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26, 739 764.
9. Calabrese V., Scapagnini G., Ravagna A., Fariello R. G., Giuffrida Stella A. M. Abraham N. G. (2002) Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J. Neurosci. Res. 68, 65 75.
10. Calabrese V., Colombrita C., Guagliano E. et al. (2005a) Protective effect of carnosine during nitrosative stress in astroglial cell cultures. Neurochem. Res. 30, 797 807.
11. Calabrese V., Ravagna A., Colombrita C., Guagliano E., Scapagnini G., Calvani M., Butterfield D. A. Giuffrida Stella A. M. (2005b) Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J. Neurosci. Res. 79, 509 521.
12. Calabrese V., Ravagna A., Scapagnini G., Catalano C., Pennisi G., Butterfield D. A. Giuffrida Stella A. M. (2005c) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 233, 145 162.
13. Calabrese V., Butterfield D. A., Scapagnini G., Stella A. M. Maines M. D. (2006) Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid. Redox Signal. 8, 444 477.
14. Camp D. M., Loeffler D. A. LeWitt P. A. (2000) L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion. J. Neurochem. 74, 1229 1240.
15. Chen J., Wersinger C. Sidhu A. (2003) Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity. J. Biol. Chem. 278, 28 089 28 100.
16. Dehmer T., Heneka M. T., Sastre M., Dichgans J. Schulz J. B. (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J. Neurochem. 88, 494 501.
17. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P. Marsden C. D. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92 97.
18. Drake J., Sultana R., Aksenova M., Calabrese V. Butterfield D. A. (2003) Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J. Neurosci. Res 74, 917 927.
19. Floor E. Wetzel M. G. (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70, 268 275.
20. Granger D. L., Taintor R. R., Boockvar K. S. Hibbs J. B. Jr. (1996) Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Meth. Enzymol. 268, 142 151.
21. Hald H. Lotharius J. (2005) Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp. Neurol. 193, 279 290.
22. Hansson O., Nylandsted J., Castilho R. F., Leist M., Jaattela M. Brundin P. (2003) Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Brain Res. 970, 47 57.
23. Ishida Y., Hashiguchi H., Todaka K., Ishizuka Y. Mitsuyama Y. (2000) Repeated administration of high dose levodopa enhances hydroxyl radical production in the rat striatum denervated with 6-hydroxydopamine. Neurosci. Lett. 290, 33 36.
24. Jansson A., Mazel T., Andbjer B., Rosen L., Guidolin D., Zoli M., Sykova E., Agnati L. F. Fuxe K. (1999) Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat. Neuroscience 91, 69 80.
25. Jenner P. (1998) Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13, 24 34.
26. Jenner P. (2003) Oxidative stress in Parkinson's disease. Ann. Neurol. 53, S26 S36.
27. Joshi G., Perluigi M., Sultana R., Agrippino R., Calabrese V. Butterfield D. A. (2006) In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane) dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem. Int. 48, 318 327.
28. Koller W. C., Silver D. E. Lieberman A. (1994) An algorithm for the management of Parkinson's disease. Neurology 44, S1 S52.
29. Li H. Dryhurst G. (1997) Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease. J. Neurochem. 69, 1530 1541.
30. Lodi R., Tonon C., Calabrese V. Schapira A. H. (2006) Friedreich's ataxia: from disease mechanisms to therapeutic interventions. Antioxid. Redox Signal. 8, 438 443.
31. Moore D. J., West A. B., Dawson V. L. Dawson T. M. (2005) Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57 87.
32. Muyderman H., Nilsson M. Sims N. R. (2004) Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J. Neurosci. 24, 8019 8028.
33. Olsson T., Hansson O., Nylandsted J., Jaattela M., Smith M. L. Wieloch T. (2004) Lack of neuroprotection by heat shock protein 70 overexpression in a mouse model of global cerebral ischemia. Exp. Brain Res. 154, 442 449.
34. Panet H., Barzilai A., Daily D., Melamed E. Offen D. (2001) Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells. J. Neurochem. 77, 391 398.
35. Park S. H., Choi W. S., Yoon S. Y., Ahn Y. S. Oh Y. J. (2004) Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant. Biochem. Biophys. Res. Commun. 322, 727 733.
36. Perier C., Tieu K., Guegan C. et al. (2005) Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl Acad. Sci. USA 102, 19 126 19 131.
37. Perluigi M., Joshi G., Sultana R., Calabrese V., De Marco C., Coccia R., Cini C. Butterfield D. A. (2006) In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J. Neurosci. Res. 84, 418 426.
38. Perry T. L., Godin D. V. Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305 310.
39. Poon H. F., Frasier M., Shreve N., Calabrese V., Wolozin B. Butterfield D. A. (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice - a model of familial Parkinson's disease. Neurobiol. Dis. 18, 492 498.
40. Poon H. F., Calabrese V., Calvani M. Butterfield D. A. (2006) Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by L-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. Antioxid. Redox Signal. 8, 381 394.
41. Saetre T., Gundersen Y., Thiemermann C., Lilleaasen P. Aasen A. O. (1998) Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 9, 109 115.
42. Salter M. Knowles R. G. (1998) Assay of NOS activity by the measurement of conversion of oxyhemoglobin to methemoglobin by NO. Methods Mol. Biol. 100, 61 65.
43. Sammut I. A., Jayakumar J., Latif N., Rothery S., Severs N. J., Smolenski R. T., Bates T. E. Yacoub M. H. (2001) Heat stress contributes to the enhancement of cardiac mitochondrial complex activity. Am. J. Pathol. 158, 1821 1831.
44. Schapira A. H., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B. Marsden C. D. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142 2145.
45. Shin M. H., Jang J. H. Surh Y. J. (2004) Potential roles of NF-kappaB and ERK1/2 in cytoprotection against oxidative cell death induced by tetrahydropapaveroline. Free Radic. Biol. Med. 36, 1185 1194.
46. Soliman M. K., Mazzio E. Soliman K. F. (2002) Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells. Life Sci. 72, 185 198.
47. Spencer J. P., Jenner A., Aruoma O. I., Evans P. J., Kaur H., Dexter D. T., Jenner P., Lees A. J., Marsden D. C. Halliwell B. (1994) Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease. FEBS Lett. 353, 246 250.
48. Stocchi F. (2005) Optimising levodopa therapy for the management of Parkinson's disease. J. Neurol. 252, IV43 IV48.
49. Sultana R., Ravagna A., Mohmmad-Abdul H., Calabrese V. Butterfield D. A. (2005) Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. 92, 749 758.
50. Takeuchi Y. Fukunaga K. (2004) Different activation of NF-kappaB by stimulation of dopamine D2L and D2S receptors through calcineurin activation. J. Neurochem. 90, 155 163.
51. Wagner J., Vitali P., Palfreyman M. G., Zraika M. Huot S. (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4- dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J. Neurochem. 38, 1241 1254.
52. Wang L. Z., Sun W. C. Zhu X. Z. (2005) Ethyl pyruvate protects PC12 cells from dopamine-induced apoptosis. Eur. J. Pharmacol. 508, 57 68.
53. Warton D. C. Tzagoloff A. (1967) Cytochrome oxidase from bovine heart mitochondria. Meth. Enzymol. 10, 245 257.
54. Yenari M. A., Giffard R. G., Sapolsky R. M. Steinberg G. K. (1999) The neuroprotective potential of heat shock protein 70 (HSP70). Mol. Med. Today 5, 525 531.
55. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696 2701.
56. Zhang J., Perry G., Smith M. A., Robertson D., Olson S. J., Graham D. G. Montine T. J. (1999) Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154, 1423 1429.